Probiotic supplementation in preterm: Feeding intolerance and hospital cost

Nutrients

Volumn 9, Issue 9, 2017, Pages 1-8

  Indrio, Flavia ^a   Riezzo, Giuseppe ^b   Tafuri, Silvio ^a   Ficarella, Maria ^a   Carlucci, Barbara ^c   Bisceglia, Massimo ^d   Polimeno, Lorenzo ^a   Francavilla, Ruggiero ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^c Ospedale A Perrino   (Italy)

^d SAN GIOVANNI DI DIO HOSPITAL   (Italy)

Author keywords

Feeding intolerance; Preterm newborn; Probiotic

Indexed keywords

ANTIBIOTIC AGENT; CALGRANULIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DEFECATION HABIT; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL MOTILITY; GESTATIONAL AGE; HEALTH CARE COST; HOSPITAL COST; HUMAN; LACTOBACILLUS REUTERI; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; NUTRITIONAL INTOLERANCE; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; CHEMISTRY; DRUG EFFECT; ECONOMICS; FECES; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CYTOKINES; DOUBLE-BLIND METHOD; FECES; FEMALE; GASTROINTESTINAL MOTILITY; GENE EXPRESSION REGULATION; HEALTH CARE COSTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LACTOBACILLUS REUTERI; LENGTH OF STAY; MALE; PROBIOTICS;

EID: 85029179044     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9090965     Document Type: Article

References (30)

1. Indrio, F.; Riezzo, G.; Cavallo, L.; Di Mauro, A.; Francavilla, R. Physiological basis of food intolerance in VLBW. J. Matern. Fetal Neonatal Med. 2011, 24, 64-66.
2. Schatzmann Peron, J.P.; Ligeiro de Oliveira, A.P.; Rizzo, L.V. It takes guts for tolerance: The phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun. Rev. 2009, 9, 1-4.
3. Isolauri, E. Development of healthy gut microbiota early in life. J. Paediatr. Child Health 2012, 48, 1-6.
4. Deshpande, G.; Rao, S.; Patole, S.; Bulsara, M. Updated Meta-analysis of Probiotics for Preventing Necrotizing Enterocolitis in Preterm Neonates. Pediatrics 2010, 125, 921-930.
5. Torrazza, R.M.; Ukhanova, M.; Wang, X.; Sharma, R.; Hudak, M.L.; Neu, J.; Mai, V. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS ONE 2013, 8, e83304, doi:10.1371/journal.pone.0083304.
6. Verhasselt, V. Neonatal tolerance under breastfeeding influence. Curr. Opin. Immunol. 2010, 22, 620-630.
7. Indrio, F.; Riezzo, G.; Raimondi, F.; Bisceglia, M.; Cavallo, L.; Francavilla, R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J. Pediatr. 2008, 152, 801-806.
8. Indrio, F.; Riezzo, G.; Raimondi, F.; Francavilla, R.M.; Montagna, O.; Valenzano, M.L.; Cavallo, L.; Boehm, G. Prebiotics improve gastric motility and gastric electrical activity in preterm newborn. J. Pediatr. Gastroenterol. Nutr. 2009, 49, 258-261.
9. Indrio, F.; Riezzo, G.; Raimondi, F.; Bisceglia, M.; Cavallo, L.; Francavilla, R. Effects of probiotic and prebiotic on gastrointestinal motility in newborns. J. Physiol. Pharmacol. 2009, 60, 27-31.
10. Liu, Y.; Fatheree, N.Y.; Mangalat, N.; Rhoads, J.M. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299, G1087-G1096.
11. Rosander, A.; Connolly, E.; Roos, S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl. Environ. Microbiol. 2008, 74, 6032-6040.
12. Griffith, G.H.; Owen, G.M.; Kirkman, S.; Shields, R. Measurement of rate of gastric emptying using chromium-51. Lancet 1966, 1, 1244-1245.
13. Siegel, J.; Wu, R.; Knight, L.; Zelac, R.E.; Stern, H.S.; Malmud, L.S. Radiation dose estimates for oral agents used in upper gastrointestinal disease. J. Nucl. Med. 1983, 24, 835-837.
14. Riezzo, G.; Indrio, F.; Montagna, O.; Tripaldi, C.; Laforgia, N.; Chiloiro, M.; Mautone, A. Gastric electrical activity and gastric emptying in term and preterm newborns. Neurogastroenterol. Mot. 2000, 12, 223-229.
15. Bolondi, L.; Bortolotti, M.; Santi, V.; Calletti, T.; Gaiani, S.; Labò, G. Measurement of gastric emptying time by real-time ultrasonography. Gastroenterology 1985, 89, 752-759.
16. Hattori, M.; Taylor, T.D. The human intestinal microbiome: A new frontier of human biology. DNA Res. 2009, 16, 1-12.
17. Nagler-Anderson, C. Man the barrier! Strategic defences in the intestinal mucosa. Nat. Rev. Immunol. 2001, 1, 59-67.
18. Sharma, R.; Young, C.; Neu, J. Molecular modulation of intestinal epithelial barrier: Contribution of microbiota. J. Biomed. Biotechnol. 2010, 2010, doi:10.1155/2010/305879.
19. Rojas, M.A.; Lozano, J.M.; Rojas, M.X.; Rodriguez, V.A.; Rondon, M.A.; Bastidas, J.A.; Perez, L.A.; Rojas, C.; Ovalle, O.; Garcia-Harker, J.E.; et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012, 130, e1113-e1120.
20. Perrier, C.; Corthésy, B. Gut permeability and food allergies. Clin. Exp. Allergy 2011, 41, 20-28.
21. Martin, C.R.; Walker, W.A. Probiotics: Role in pathophysiology and prevention in necrotizing enterocolitis. Semin. Perinatol. 2008, 32, 127-137.
22. Kelles, A.; Janssens, J.; Tack, J. IL-1beta and IL-6 excite neurones and suppress cholinergic neurotransmission in the myenteric plexus of the guinea pig. Neurogastroenterol. Motil. 2000, 12, 531-538.
23. Kindt, S.; Vanden Berghe, P.; Boesmans, W.; Roosen, L.; Tack, J. IL-1beta exposure alters neurotransmitter and electrically induced Ca(2+) responses in the myenteric plexus. Neurogastroenterol. Motil. 2010, 22, doi:10.1111/j.1365-2982.2009.01414.x.
24. Moles, L.; Escribano, E.; de Andrés, J.; Montes, M.T.; Rodríguez, J.M.; Jiménez, E.; Sáenz de Pipaón, M.; Espinosa-Martos, I. Administration of Bifidobacterium breve PS12929 and Lactobacillus salivarius PS12934, two strains isolated from human milk, to very low and extremely low birth weight preterm infants: A pilot study. J. Immunol. Res. 2015, 2015, doi:10.1155/2015/538171.
25. Campeotto, F.; Suau, A.; Kapel, N.; Magne, F.; Viallon, V.; Ferraris, L.; Waligora-Dupriet, A.J.; Soulaines, P.; Leroux, B.; Kalach, N.; et al. A fermented formula in pre-term infants: Clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br. J. Nutr. 2011, 105, 1843-1851.
26. Cryan, J.F.; O’Mahony, S.M. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol. Motil. 2011, 23, 187-192.
27. Collins, S.M.; Bercik, P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009, 136, 2003-2014.
28. Calder, P.C. Feeding the immune system. Proc. Nutr. Soc. 2013, 72, 299-309.
29. Urbanska, M.; Szajewska, H. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: A review of the current evidence. Eur. J. Pediatr. 2014, 173, 1327-1337.
30. Wu, R.Y.; Pasyk, M.; Wang, B.; Forsythe, P.; Bienenstock, J.; Mao, Y.K.; Sharma, P.; Stanisz, A.M.; Kunze, W.A. Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterol. Motil. 2013, 25, e205-e214.